BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37216827)

  • 1. CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease.
    Chen J; Hao Y; Xu P; Bian D; Han L; Wu X; Zhuang Z; Wang J; Luo Y
    Biochem Biophys Res Commun; 2023 Jul; 667():120-126. PubMed ID: 37216827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    Min-DeBartolo J; Schlerman F; Akare S; Wang J; McMahon J; Zhan Y; Syed J; He W; Zhang B; Martinez RV
    PLoS One; 2019; 14(12):e0226854. PubMed ID: 31891606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
    Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
    Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease.
    Toita R; Kang JH
    Toxicol Lett; 2020 Oct; 332():1-6. PubMed ID: 32579995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease.
    Han M; Piorońska W; Wang S; Nwosu ZC; Sticht C; Wang S; Gao Y; Ebert MP; Dooley S; Meyer C
    Cell Death Dis; 2020 Feb; 11(2):104. PubMed ID: 32029710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in diet-induced steatotic disease in Cyp2b-null mice.
    Heintz MM; McRee R; Kumar R; Baldwin WS
    PLoS One; 2020; 15(3):e0229896. PubMed ID: 32155178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of TRPC3 or TRPC6 Fails to Attenuate the Formation of Inflammation and Fibrosis in Non-alcoholic Steatohepatitis.
    Nishiyama K; Toyama C; Kato Y; Tanaka T; Nishimura A; Nagata R; Mori Y; Nishida M
    Biol Pharm Bull; 2021; 44(3):431-436. PubMed ID: 33642551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice.
    Ishikawa H; Hayakawa M; Baatartsogt N; Kakizawa N; Ohto-Ozaki H; Maruyama T; Miura K; Suzuki K; Rikiyama T; Ohmori T
    Sci Rep; 2022 Jul; 12(1):11634. PubMed ID: 35804007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway.
    Conde de la Rosa L; Garcia-Ruiz C; Vallejo C; Baulies A; Nuñez S; Monte MJ; Marin JJG; Baila-Rueda L; Cenarro A; Civeira F; Fuster J; Garcia-Valdecasas JC; Ferrer J; Karin M; Ribas V; Fernandez-Checa JC
    J Hepatol; 2021 Jun; 74(6):1429-1441. PubMed ID: 33515644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
    Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
    Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
    Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
    J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease.
    Lee N; Heo YJ; Choi SE; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ
    Biochem Biophys Res Commun; 2022 Jan; 588():154-160. PubMed ID: 34971904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse.
    Takano K; Kaneda M; Aoki Y; Fujita N; Chiba S; Michihara S; Han LK; Takahashi R
    J Nat Med; 2024 Jun; 78(3):514-524. PubMed ID: 38498120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease.
    Mesarwi OA; Shin MK; Bevans-Fonti S; Schlesinger C; Shaw J; Polotsky VY
    PLoS One; 2016; 11(12):e0168572. PubMed ID: 28030556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
    Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis.
    Zhang X; Li S; Zhou Y; Su W; Ruan X; Wang B; Zheng F; Warner M; Gustafsson JÅ; Guan Y
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3181-3185. PubMed ID: 28270609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis, steatohepatitis, and fibrosis in male mice.
    Upadhyay KK; Choi EK; Foisner R; Omary MB; Brady GF
    Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G184-G195. PubMed ID: 37366543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK.
    Zhu M; Jia Z; Yan X; Liu L; Fang C; Feng M; Dai Y; Zhang Y; Wu H; Huang B; Li Y; Liu J; Xiao H
    J Ethnopharmacol; 2022 Sep; 295():115427. PubMed ID: 35654350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.